tiprankstipranks
Sysmex Corporation (JP:6869)
:6869
Japanese Market
Want to see JP:6869 full AI Analyst Report?

Sysmex (6869) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

6869 Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Sysmex
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

6869 Stock 12 Month Forecast

There Are No Analyst Ratings for JP:6869 In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

6869 Financial Forecast

6869 Earnings Forecast

Next quarter’s earnings estimate for 6869 is ¥9.47 with a range of ¥8.33 to ¥10.29. The previous quarter’s EPS was ¥2.84. 6869 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 6869 has Performed in-line its overall industry.
Next quarter’s earnings estimate for 6869 is ¥9.47 with a range of ¥8.33 to ¥10.29. The previous quarter’s EPS was ¥2.84. 6869 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 6869 has Performed in-line its overall industry.

6869 Sales Forecast

Next quarter’s sales forecast for 6869 is ¥117.14B with a range of ¥110.16B to ¥122.00B. The previous quarter’s sales results were ¥138.84B. 6869 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 6869 has Performed in-line its overall industry.
Next quarter’s sales forecast for 6869 is ¥117.14B with a range of ¥110.16B to ¥122.00B. The previous quarter’s sales results were ¥138.84B. 6869 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 6869 has Performed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
¥1,500
Hold
4.38%
Upside
Reiterated
03/16/26
Sysmex (SSMXF) Gets a Hold from Jefferies
Goldman Sachs Analyst forecast on JP:6869
Goldman Sachs
Goldman Sachs
¥2,350¥2,000
Buy
39.18%
Upside
Reiterated
02/13/26
Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Sysmex (SSMXF)
Morgan Stanley Analyst forecast on JP:6869
Morgan Stanley
Morgan Stanley
¥2,800¥2,400
Buy
67.01%
Upside
Reiterated
11/20/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neogen (NASDAQ: NEOG) and Sysmex (Other OTC: SSMXF)
Macquarie Analyst forecast on JP:6869
Macquarie
Macquarie
¥2,200¥2,000
Hold
39.18%
Upside
Reiterated
10/14/25
Macquarie Keeps Their Hold Rating on Sysmex (SSMXF)
J.P. Morgan Analyst forecast on JP:6869
J.P. Morgan
J.P. Morgan
¥3,000¥2,500
Buy
73.97%
Upside
Reiterated
10/02/25
Sysmex Corporation (6869:JP) (SSMXY) PT Lowered to JPY2,500 at JPMorganJPMorgan analyst Naoko Saito lowered the price target on Sysmex Corporation (6869:JP) (OTC: SSMXY) to JPY2,500.00 (from JPY3,000.00) while maintaining a Overweight rating.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Jefferies
¥1,500
Hold
4.38%
Upside
Reiterated
03/16/26
Sysmex (SSMXF) Gets a Hold from Jefferies
Goldman Sachs Analyst forecast on JP:6869
Goldman Sachs
Goldman Sachs
¥2,350¥2,000
Buy
39.18%
Upside
Reiterated
02/13/26
Analysts Are Bullish on These Healthcare Stocks: Alnylam Pharma (ALNY), Sysmex (SSMXF)
Morgan Stanley Analyst forecast on JP:6869
Morgan Stanley
Morgan Stanley
¥2,800¥2,400
Buy
67.01%
Upside
Reiterated
11/20/25
Analysts Have Conflicting Sentiments on These Healthcare Companies: Neogen (NASDAQ: NEOG) and Sysmex (Other OTC: SSMXF)
Macquarie Analyst forecast on JP:6869
Macquarie
Macquarie
¥2,200¥2,000
Hold
39.18%
Upside
Reiterated
10/14/25
Macquarie Keeps Their Hold Rating on Sysmex (SSMXF)
J.P. Morgan Analyst forecast on JP:6869
J.P. Morgan
J.P. Morgan
¥3,000¥2,500
Buy
73.97%
Upside
Reiterated
10/02/25
Sysmex Corporation (6869:JP) (SSMXY) PT Lowered to JPY2,500 at JPMorganJPMorgan analyst Naoko Saito lowered the price target on Sysmex Corporation (6869:JP) (OTC: SSMXY) to JPY2,500.00 (from JPY3,000.00) while maintaining a Overweight rating.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sysmex

3 Months
Ryotaro HayashiMorgan Stanley
Success Rate
1/4 ratings generated profit
25%
Average Return
-0.85%
Copying Ryotaro Hayashi's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -0.85% per trade.
1 Year
Ryotaro HayashiMorgan Stanley
Success Rate
1/4 ratings generated profit
25%
Average Return
-10.17%
Copying Ryotaro Hayashi's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -10.17% per trade.
2 Years
Ryotaro HayashiMorgan Stanley
Success Rate
1/4 ratings generated profit
25%
Average Return
-9.38%
Copying Ryotaro Hayashi's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -9.38% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

6869 Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
1
1
1
0
0
Hold
0
1
1
1
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
1
2
2
1
0
In the current month, 6869 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 6869 average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

6869 Stock Forecast FAQ

What is JP:6869’s average 12-month price target, according to analysts?
Currently, no data Available
What is JP:6869’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for JP:6869, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Sysmex Corporation a Buy, Sell or Hold?
      Currently, no data Available
      What is Sysmex Corporation’s share price target?
      Currently, no data Available
      What do analysts say about Sysmex Corporation?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Sysmex Corporation?
      To buy shares of JP:6869, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.